Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseases

Journal of the American Academy of Dermatology

Volumn 69, Issue 4, 2013, Pages 649-650

  Machet, Laurent ^a,b   Samimi, Mahtab ^a,b   Delage, Maïa ^b   Paintaud, Gilles ^a,b   Maruani, Annabel ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; METHOTREXATE;

ANKYLOSING SPONDYLITIS; COMORBIDITY; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFLAMMATORY DISEASE; LETTER; PRIORITY JOURNAL; PSORIASIS; PYODERMA GANGRENOSUM; RISK ASSESSMENT; SAPHO SYNDROME; SUPPURATIVE HIDRADENITIS; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

EID: 84884300223     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.04.032     Document Type: Article

References (5)

1. F. Canoui-Poitrine, J.E. Revuz, P. Wolkenstein, C. Viallette, G. Gabison, and F. Pouget Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity J Am Acad Dermatol 61 2009 51 57
2. P.V. Rambhatla, H.W. Lim, and I. Hamzavi A systematic review of treatments for hidradenitis suppurativa Arch Dermatol 148 2012 439 446
3. J.L. Blok, S. van Hattem, M.F. Jonkman, and B. Horváth Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review Br J Dermatol 168 2013 243 252
4. van Rappard DC, Limpens J, Mekkes JR. The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review. J Dermatolog Treat doi: 10.3109/09546634.2012.674193. Published online April 12, 2012.
5. A. Grant, T. Gonzalez, M.O. Montgomery, V. Cardenas, and F.A. Kerdel Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial J Am Acad Dermatol 62 2010 205 217